BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Tolera Therapeutics, Inc. Honored as One of the 2010 'Michigan 50 Companies to Watch'


4/7/2010 8:16:12 AM

KALAMAZOO, Mich., April 7 /PRNewswire/ -- Tolera Therapeutics has been recognized as one of the 2010 "Michigan 50 Companies to Watch," an awards program sponsored by the Edward Lowe Foundation and presented by Michigan Celebrates Small Business.

Tolera is a Kalamazoo, Michigan based clinical stage company with a highly specific T-cell targeting monoclonal antibody technology (anti-TCR) for immune modulation. This technology has broad application potential in T-cell mediated disease such as transplant rejection, autoimmune disease (e.g. type 1 diabetes and multiple sclerosis) and hematological malignancies (e.g. leukemia). Tolera will initiate Phase 2 human clinical trials this summer for its lead drug candidate TOL101.

"Now 300 strong, the second-stage businesses that comprise the Michigan 50 Companies to Watch have not only persevered through challenging times, but also found opportunities to grow," says Penny Lewandowski, director of entrepreneurship development at the Edward Lowe Foundation. "They continue to hire and develop new markets for their products and services. Some have attracted significant amounts of venture capital, while others have been awarded prestigious federal grants. They are making a substantial difference in their communities -- and their industries. Our 2010 inductees are proof that entrepreneurs are, and always have been, the future of Michigan's economy."

Winners were selected by Michigan-based judges from the banking, economic development, entrepreneurship development and venture capital communities.

PNC Bank is the lead underwriter for Michigan Celebrates Small Business, with additional underwriting support from Clark Hill PLC, Michigan Economic Development Corporation, Michigan Certified Development Corporation, Accident Fund Insurance Company of America, Comcast Business Class, Comcast Spotlight, and Dynamic Edge.

Information about the 2010 Michigan 50 Companies to Watch program can be found at http://Michigan.CompaniesToWatch.org. For information about Michigan Celebrates Small Business, visit http://MichiganCelebrates.biz.

Tolera Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES